ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, the fusion of breakpoint cluster region-tyrosine-protein kinase with tyrosine-protein kinase ABL (BCR-ABL) seen in t (9; 22) is a driving mutation and characteristic of CML [7].